XML 87 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statement of Stockholders' Equity (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Total Molycorp Stockholders
Common Stock
Series A Mandatory Convertible Preferred Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Surplus (Deficit) Accumulated During the Development Stage
Noncontrolling interest
Class A Common Stock
Balance at Jun. 12, 2008                  
Increase (Decrease) in Stockholders' Equity                  
Issuance of shares for cash on various dates at $2.60, $4.68, $2.37 per share in 2010, 2009, and 2008, respectively $ 92,000 $ 92,000     $ 91,961       $ 39
Issuance of shares for cash on various dates at $2.60, $4.68, $2.37 per share in 2010, 2009, and 2008, respectively (in shares)                 38,762,268
Stock-based compensation, at $2.24 per share based on a set dollar amount for November 6, 2008 (Note 17) 150 150     150        
Stock-based compensation, at $2.24 per share based on a set dollar amount for November 6, 2008 (Note 17) (in shares)                 66,957
Net (loss) income (14,074) (14,074)         (14,074)    
Balance at Dec. 31, 2008 78,076 78,076     92,111   (14,074)   39
Balance (in shares) at Dec. 31, 2008                 38,829,225
Increase (Decrease) in Stockholders' Equity                  
Issuance of shares for cash on various dates at $2.60, $4.68, $2.37 per share in 2010, 2009, and 2008, respectively 18,004 18,004     18,000       4
Issuance of shares for cash on various dates at $2.60, $4.68, $2.37 per share in 2010, 2009, and 2008, respectively (in shares)                 3,844,858
Conversion of short term borrowings from member and related accrued interest in common shares on November 15, 2009 at $2.96 per share based on a contractual price 6,831 6,831     6,829       2
Conversion of short term borrowings from member and related accrued interest in common shares on November 15, 2009 at $2.96 per share based on a contractual price (in shares)                 2,303,033
Exercise of employee options on February 1, 2010 and September 4, 2009 at $2.37 per share 50 50     50        
Exercise of employee options on February 1, 2010 and September 4, 2009 at $2.37 per share (in shares)                 21,069
Stock-based compensation, at $2.24 per share based on a set dollar amount for November 6, 2008 (Note 17) 241 241     241        
Net (loss) income (28,587) (28,587)         (28,587)    
Balance at Dec. 31, 2009 74,615 74,615     117,231   (42,661)   45
Balance (in shares) at Dec. 31, 2009                 44,998,185
Increase (Decrease) in Stockholders' Equity                  
Issuance of shares for cash on various dates at $2.60, $4.68, $2.37 per share in 2010, 2009, and 2008, respectively 15,000 15,000     14,994       6
Issuance of shares for cash on various dates at $2.60, $4.68, $2.37 per share in 2010, 2009, and 2008, respectively (in shares)                 5,767,670
Exercise of employee options on February 1, 2010 and September 4, 2009 at $2.37 per share 300 300     300        
Exercise of employee options on February 1, 2010 and September 4, 2009 at $2.37 per share (in shares)                 126,405
Conversion of Class A stock to common stock in conjunction with the IPO on August 3, 2010     51           (51)
Conversion of Class A stock to common stock in conjunction with the IPO on August 3, 2010 (in shares)     50,892,260           (50,892,260)
Sale of shares of common stock at $14.00 per share in IPO 2010, net of offering costs of $29.2 million 378,633 378,633 29   378,604        
Sale of shares of common stock at $14.00 per share in IPO 2010, net of offering costs of $29.2 million (in shares)     29,128,700            
Conversion of Class B stock to common stock in conjunction with the IPO on August 3, 2010 28,663 28,663 2   28,661        
Conversion of Class B stock to common stock in conjunction with the IPO on August 3, 2010 (in shares)     2,232,740            
Stock-based compensation, at $2.24 per share based on a set dollar amount for November 6, 2008 (Note 17) 76 76     76        
Stock-based compensation, at $2.24 per share based on a set dollar amount for November 6, 2008 (Note 17) (in shares)     37,500            
Net (loss) income (50,774) (50,774)         (50,774)    
Balance at Dec. 31, 2010 446,513 446,513 82   539,866   (93,435)    
Balance (in shares) at Dec. 31, 2010     82,291,200            
Increase (Decrease) in Stockholders' Equity                  
Sale of Series A mandatory convertible preferred stock on February 16, 2011 at $100.00 per share, net of underwriting 199,642 199,642   2 199,640        
Sale of Series A mandatory convertible preferred stock on February 16, 2011 at $100.00 per share, net of underwriting (in shares)       2,070,000          
Stock-based compensation, at $2.24 per share based on a set dollar amount for November 6, 2008 (Note 17) 4,671 4,671     4,671        
Stock-based compensation, at $2.24 per share based on a set dollar amount for November 6, 2008 (Note 17) (in shares)     11,424            
Issuance of shares for interest in Molycorp Silmet on April 1, 2011 at $45.60 per share 81,475 72,655 2   72,653     8,820  
Issuance of shares for interest in Molycorp Silmet on April 1, 2011 at $45.60 per share (in shares)     1,593,419            
Component of convertible debt 36,227 36,227     36,227        
Deferred taxes on component of convertible debt (14,138) (14,138)     (14,138)        
Net (loss) income 118,334 117,526         117,526 808  
Preferred dividends (9,013) (9,013)         (9,013)    
Other comprehensive income (8,481) (8,058)       (8,058)   (423)  
Acquisition of noncontrolling interest (10,000) (795)     (372) (423)   (9,205)  
Balance at Dec. 31, 2011 845,230 845,230 84 2 838,547 (8,481) 15,078    
Balance (in shares) at Dec. 31, 2011     83,896,043 2,070,000          
Increase (Decrease) in Stockholders' Equity                  
Stock-based compensation, at $2.24 per share based on a set dollar amount for November 6, 2008 (Note 17) 1,408 1,408     1,408        
Issuance of shares for investment from Molymet on March 8, 2012 at $31.218 per share, net of stock issuance costs (Note 15) 390,093 390,093 12   390,081        
Issuance of shares for investment from Molymet on March 8, 2012 at $31.218 per share, net of stock issuance costs (Note 15) (in shares)     12,500,000            
Net (loss) income (3,478) (3,478)         (3,478)    
Preferred dividends (2,846) (2,846)         (2,846)    
Other comprehensive income 2,530 2,530       2,530      
Balance at Mar. 31, 2012 $ 1,232,937 $ 1,232,937 $ 96 $ 2 $ 1,230,036 $ (5,951) $ 8,754    
Balance (in shares) at Mar. 31, 2012     96,396,043 2,070,000